Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Tektonidou

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Seminars in Arthritis and Rheumatism|July 5, 2022
Autoinflammatory syndromes with coexisting variants in Mediterranean FeVer and other genes: Utility of multiple gene screening and the possible impact of gene dosageAnastasios Karamanakos, Maria Tektonidou, Olga Vougiouka, et al.
Mediterranean Journal of Rheumatology|September 21, 2022
Real-Life Outcome of Lupus Nephritis with Current Therapies: Study Protocol of a Multicentre Observational StudyMaria Pappa, Maria Kosmetatou, Antonia Elezoglou, et al.
Autoimmunity Reviews|December 3, 2014
Patient-level analysis of five international cohorts further confirms the efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodiesLaurent Arnaud, Alexis Mathian, Hervé Devilliers, et al.
Autoimmunity Reviews|November 6, 2013
Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: an international and collaborative meta-analysisLaurent Arnaud, Alexis Mathian, Amelia Ruffatti, et al.
Rheumatology International|June 29, 2020
Current understanding and future perspectives of brain-heart-kidney axis in psoriatic arthritisGeorge Markousis-Mavrogenis, Michael T Nurmohamed, Loukia Koutsogeorgopoulou, et al.
Autoimmunity Reviews|February 3, 2015
The relevance of "non-criteria" clinical manifestations of antiphospholipid syndrome: 14th International Congress on Antiphospholipid Antibodies Technical Task Force Report on Antiphospholipid Syndrome Clinical FeaturesMirhelen M Abreu, Adriana Danowski, Denis G Wahl, et al.
Arthritis Research & Therapy|December 6, 2018
Prevalence of comorbidities in systemic sclerosis versus rheumatoid arthritis: a comparative, multicenter, matched-cohort studyStylianos Panopoulos, Maria Tektonidou, Alexandros A Drosos, et al.
The Journal of Clinical Investigation|August 8, 2020
Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosisPanagiotis Skendros, Alexandros Mitsios, Akrivi Chrysanthopoulou, et al.
Annals of the Rheumatic Diseases|September 14, 2010
Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis TrialFrédéric A Houssiau, David D'Cruz, Shirish Sangle, et al.
Annals of the Rheumatic Diseases|March 12, 2015
Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritisFarah Tamirou, David D'Cruz, Shirish Sangle, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Seminars in Arthritis and Rheumatism|July 5, 2022
Autoinflammatory syndromes with coexisting variants in Mediterranean FeVer and other genes: Utility of multiple gene screening and the possible impact of gene dosageAnastasios Karamanakos, Maria Tektonidou, Olga Vougiouka, et al.
Mediterranean Journal of Rheumatology|September 21, 2022
Real-Life Outcome of Lupus Nephritis with Current Therapies: Study Protocol of a Multicentre Observational StudyMaria Pappa, Maria Kosmetatou, Antonia Elezoglou, et al.
Autoimmunity Reviews|December 3, 2014
Patient-level analysis of five international cohorts further confirms the efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodiesLaurent Arnaud, Alexis Mathian, Hervé Devilliers, et al.
Autoimmunity Reviews|November 6, 2013
Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: an international and collaborative meta-analysisLaurent Arnaud, Alexis Mathian, Amelia Ruffatti, et al.
Rheumatology International|June 29, 2020
Current understanding and future perspectives of brain-heart-kidney axis in psoriatic arthritisGeorge Markousis-Mavrogenis, Michael T Nurmohamed, Loukia Koutsogeorgopoulou, et al.
Autoimmunity Reviews|February 3, 2015
The relevance of "non-criteria" clinical manifestations of antiphospholipid syndrome: 14th International Congress on Antiphospholipid Antibodies Technical Task Force Report on Antiphospholipid Syndrome Clinical FeaturesMirhelen M Abreu, Adriana Danowski, Denis G Wahl, et al.
Arthritis Research & Therapy|December 6, 2018
Prevalence of comorbidities in systemic sclerosis versus rheumatoid arthritis: a comparative, multicenter, matched-cohort studyStylianos Panopoulos, Maria Tektonidou, Alexandros A Drosos, et al.
The Journal of Clinical Investigation|August 8, 2020
Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosisPanagiotis Skendros, Alexandros Mitsios, Akrivi Chrysanthopoulou, et al.
Annals of the Rheumatic Diseases|September 14, 2010
Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis TrialFrédéric A Houssiau, David D'Cruz, Shirish Sangle, et al.
Annals of the Rheumatic Diseases|March 12, 2015
Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritisFarah Tamirou, David D'Cruz, Shirish Sangle, et al.
Pageof 6